Du är här

2014-05-13

PCI Biotech: Minutes from Annual General Meeting 2014

Lysaker, 13 May 2014

The Annual General Meeting in PCI Biotech Holding ASA was held 13 May 2014.
All propositions according the call were approved. Minutes of the Annual
General Meeting is attached (in Norwegian only).

In the Annual General Meeting, Hilde H. Steineger was elected new Board Member
of PCI Biotech Holding ASA.

Hilde H. Steineger (b. 1966) is a Norwegian citizen with a PhD in medical
biochemistry and with over 20 years experience in the intersection of
research and commercialization from different parts of the pharmaceutical
industry. She has since 2009 worked in Pronova, now part of the BASF Group,
where she is currently Head of Global Omega-3 Innovation Management. She
began her career at Nycomed Pharma in 1999, first in clinical development and
then with international marketing. In 2001, she was an analyst at Nordea
responsible for coverage of the biotechnology and pharmaceutical industries
on the Oslo Stock Exchange and Copenhagen Stock Exchange. After a period as
an independent consultant (2003-2005) she became a senior associate in Neomed
Management, an international investment company with focus on the health
industry. Hilde also has extensive board experience in the pharmaceutical
industry (including Algeta ASA and Clavis Pharma ASA) and she currently has
two other board positions in the sector: Cortendo AB and Weifa AS.

For more information about PCI Biotech, visit: www.pcibiotech.com

For further information, please contact:
Ronny Skuggedal, CFO
E-mail:rs@pcibiotech.no

Office: +47 67 11 54 00
Mobile: +47 94 00 57 57

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

PCIB Holding Minutes Annual General Meeting 2014
http://hugin.info/139147/R/1784954/611820.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: PCI Biotech Holding via Globenewswire

HUG#1784954

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.